Hospital Virgen del Camino -ko ikertzaileekin lankidetzan egindako argitalpenak (18)

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

  2. Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease

    European Journal of Vascular and Endovascular Surgery, Vol. 63, Núm. 4, pp. 648-656

  3. Neutrophil-to-lymphocyte ratio as a cardiovascular risk biomarker in psoriasis: A comprehensive review

    JEADV Clinical Practice, Vol. 1, Núm. 4, pp. 397-406

2021

  1. Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke

    Journal of Neuroinflammation, Vol. 18, Núm. 1

  2. Association of sdf1 and mmp12 with atherosclerosis and inflammation: Clinical and experimental study

    Life, Vol. 11, Núm. 5

  3. Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients

    Frontiers in Neurology, Vol. 12

  4. The role of circulating biomarkers in peripheral arterial disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

2020

  1. Circulating TIMP-1 is associated with hematoma volume in patients with spontaneous intracranial hemorrhage

    Scientific Reports, Vol. 10, Núm. 1

  2. Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD)

    Journal of Extracellular Vesicles, Vol. 9, Núm. 1

  3. MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. MMP10 Promotes Efficient Thrombolysis After Ischemic Stroke in Mice with Induced Diabetes

    Translational Stroke Research, Vol. 10, Núm. 4, pp. 389-401

  3. Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease

    Journal of Vascular Surgery, Vol. 66, Núm. 5, pp. 1527-1533.e1

2015

  1. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease

    Journal of Vascular Surgery, Vol. 61, Núm. 2, pp. 428-435

2013

  1. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism

    International Journal of Cancer, Vol. 133, Núm. 9, pp. 2157-2164

1999

  1. Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states

    Thrombosis Research, Vol. 93, Núm. 2, pp. 71-78

1995

  1. Evaluation of the fibrinolytic system in full-term neonates

    International Journal of Clinical and Laboratory Research, Vol. 25, Núm. 3, pp. 149-152